Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampicin in Children With Newly Diagnosed Uncomplicated Tuberculosis

NCT04437836 is registered in ClinicalTrials.gov with Kilimanjaro Clinical Research Institute as lead sponsor.

NCT NCT04437836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04437836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampicin in Children With Newly Diagnosed Uncomplicated Tuberculosis
Lead sponsor
Kilimanjaro Clinical Research Institute
Phase
Phase 1/2
Overall status
Completed
Start date
July 1, 2019
Completion date
December 31, 2023
Enrollment
31 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

clinical trial